Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

BCAP Activators

BCAP activators comprise a specialized class of chemical compounds known for their ability to modulate the activity of B-cell adapter for PI3K (BCAP), a crucial signaling protein in immune cells, particularly B lymphocytes. BCAP plays a pivotal role in orchestrating intracellular signaling pathways initiated by various immune receptors, such as B-cell receptors (BCRs) and Toll-like receptors (TLRs). These activators are designed to selectively target and enhance the function of BCAP, thereby influencing the activation of downstream signaling cascades in immune cells. At the molecular level, BCAP activators typically work by binding to specific regions of the BCAP protein, potentially inducing conformational changes that promote its interaction with other signaling molecules, ultimately amplifying immune responses.

The study of BCAP activators is essential for gaining a deeper understanding of immune cell signaling and the intricate molecular events that govern immune responses. Research in this field primarily focuses on elucidating the precise molecular mechanisms by which these compounds impact BCAP's function and their downstream effects on immune cell activation. Understanding the role of BCAP activators contributes to our broader knowledge of immunology and the complex web of signaling pathways involved in immune cell activation and regulation. Moreover, these compounds provide valuable tools for researchers seeking to investigate the fine-tuned mechanisms that govern immune responses, ultimately advancing our understanding of the immune system's role in health and disease and offering potential insights into immunomodulation in various scientific and biomedical contexts.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PKC activators; might influence BCAP expression through B cell activation pathways.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Bruton's tyrosine kinase inhibitor; could modulate BCAP expression by influencing BCR signaling.

R788

901119-35-5sc-364597
sc-364597A
2 mg
50 mg
$405.00
$4000.00
2
(0)

Syk inhibitor; might modulate BCAP expression in relation to B cell receptor signaling.

CAL-101

870281-82-6sc-364453
10 mg
$193.00
4
(1)

PI3Kδ inhibitor; potential influence on BCAP expression due to its role in the PI3K pathway.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid that can modulate B cell responses; potential influence on BCAP.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor; might influence BCAP expression given its role in PI3K-related pathways.

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$98.00
$171.00
$425.00
$1560.00
12
(2)

TLR4 agonist; could influence BCAP expression in the context of B cell activation.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$67.00
$284.00
6
(1)

TLR7 agonist; might influence BCAP expression during B cell activation.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Immunomodulatory; potential effects on BCAP expression in the context of B cell responses.